Pharmaceutical Pricing and Reimbursement Conference

July 26-27, 2010

Impact of Healthcare Reform on Reimbursement Strategy

Matt Sarnes, PharmD and Ana Stojanovska will lead this session which will focus on examining the latest national and state-level health policy changes.  Xcenda's managed markets and reimbursement strategy experts will discuss the impact of these developments on pre-, peri- and post-launch reimbursement strategy development.  We will offer new insights on how to incorporate some of these developments into your overall strategic and tactical plans.  Specifically, we will discuss:

• Drug payment changes and mechanisms
• Compendia developments
• Quality and outcomes research opportunities
• Follow-on-biologics
• Expanded coverage and market reforms
  

Register now for the ExL Pharma Pricing & Reimbursement Conference.